Literature DB >> 25422231

Prognosis of eight Chinese cases of primary vaginal yolk sac tumor with a review of the literature.

Qiong-Lan Tang1, Xue-Feng Jiang, Xiao-Ping Yuan, Yong Liu, Lin Zhang, Xiao-Feng Tang, Jia-Jia Zhou, Hai-Gang Li, Jian-Pei Fang, Lin Xue.   

Abstract

BACKGROUND: Primary vaginal yolk sac tumor is a rare malignancy in the pediatric population, and a diagnostic challenge and appropriate initial treatment remains unsolved. The aim of this study was to investigate the clinicopathologic features, treatment and prognosis of this tumor.
MATERIALS AND METHODS: Eight cases of primary vaginal yolk sac tumor were reported with a literature review.
RESULTS: There were 4 pure yolk sac tumor cases and four mixed germ cell tumors containing yolk sac tumor element, including two cases with embryonal carcinoma and two cases with embryonal carcinoma and dysgerminoma. Partial vaginectomy was performed in four cases and all patients received chemotherapy. 85 cases in literatures were reviewed and 9 cases were misdiagnosed. Follow-up data was available in 77 cases and 5-year overall survival rate was 87.6%. 5-year survival rate of biopsy with chemotherapy, conservative surgery with chemotherapy and radical surgery with chemotherapy was 91.1%, 100% and 28.6%, respectively (p<0.001). Compared to cases without relapse or metastasis after initial treatment, patients with relapse or metastasis had a shorter overall survival (35.6% vs 96.6%, p<0.001).
CONCLUSIONS: Mixed germ cell tumor containing yolk sac tumor element was not uncommon and partial vaginectomy may be a good choice for primary vaginal mixed yolk sac tumor type to eradicate local tumor cells and provide complete information for pathological diagnosis and postoperative adjuvant therapy.

Entities:  

Mesh:

Year:  2014        PMID: 25422231     DOI: 10.7314/apjcp.2014.15.21.9395

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  2 in total

1.  Primary vaginal endodermal sinus tumor in infants and children: experience from a tertiary center.

Authors:  Min Yin; Jiaxin Yang; Tao Wang; Sijian Li; Xinyue Zhang
Journal:  BMC Pediatr       Date:  2022-10-07       Impact factor: 2.567

2.  Tailored therapy and long-term surveillance of malignant germ cell tumors in the female genital system: 10-year experience.

Authors:  Qianying Zhao; Jiaxin Yang; Dongyan Cao; Jiangna Han; Kaifeng Xu; Yongjian Liu; Keng Shen
Journal:  J Gynecol Oncol       Date:  2016-05       Impact factor: 4.401

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.